J. Powell
Molecular Biology · Immunity · 2004–2020
A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 75 citations into it; #17,578 of 17,773 by trust here, #11,207 by citations
- Cancer Research — 52 citations into it
- Oncology — 33 citations into it
Whom J. Powell trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- David M. Sabatini
- Ronald H. Schwartz
- N. Hay
- D. Munn
- M. Battaglia
- M. V. Vander Heiden
- A. Mellor
- M. Laplante
Who trusts J. Powell overall
Papers from J. Powell's perspective
Ordered by how strongly the researchers J. Powell trusts endorse each paper. Same corpus, a different order for every researcher.
- Upstream and downstream of mTOR. (Genes & Development)
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
- mTOR and cancer: insights into a complex relationship (Nature Reviews. Cancer)
- The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells (Journal of Experimental Medicine)
- Defining the role of mTOR in cancer. (Cancer Cell)
- mTOR signaling at a glance (Journal of Cell Science)
- TOR, a central controller of cell growth. (Cell)
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (Science)
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. (Genes & Development)
- Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling (2011) — 935 citations
- Regulation of Immune Responses by mTOR (2011) — 821 citations
- Metabolism of immune cells in cancer (2020) — 705 citations
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion (2019) — 978 citations
- The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. (2009) — 1,280 citations
- Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR21 (2006) — 737 citations
- Role of LAG-3 in regulatory T cells. (2004) — 1,284 citations